FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3683411000001104: Nalidixic acid 500mg tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22092101000001117 Nalidixic acid 500mg tablets 56 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22092201000001112 Nalidixic acid 500mg tablets 56 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nalidixic acid 500mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet Is pack of Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet Has active ingredient Nalidixic acid false Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet Has VMP Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet Has specific active ingredient Nalidixic acid true Inferred relationship Existential restriction modifier
Nalidixic acid 500mg tablets 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Is a True Nalidixic acid 500mg tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start